SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-24-000026
Filing Date
2024-08-01
Accepted
2024-08-01 07:07:46
Documents
15
Period of Report
2024-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20240801.htm   iXBRL 8-K 30760
2 EX-99.1 ex991-q2x2024.htm EX-99.1 742451
6 GRAPHIC image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-24-000026.txt   957241

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20240801.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20240801_lab.xml EX-101.LAB 22746
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20240801_pre.xml EX-101.PRE 13049
17 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20240801_htm.xml XML 2889
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 241164192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)